Back
Mitsui Fudosan Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
39
MTSFF
Mitsui Fudosan
Last Price:
9.82
Seasonality Move:
1.01%
Sell
14
ITCI
Intra-Cellular Therapies
Last Price:
73.33
Seasonality Move:
39.33%
Sell
39
Mitsui Fudosan (MTSFF)
is a Sell
Is Mitsui Fudosan a Buy, Sell or Hold?
- The current Mitsui Fudosan [MTSFF] share price is $9.82. The Score for MTSFF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- MTSFF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $73.21. The Score for ITCI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MTSFF Stock Price Chart
What is Mitsui Fudosan's stock price today?
-
The Mitsui Fudosan share price today is $9.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTSFF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $73.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
MTSFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 44.1 | Sell |
| Chaikin Money Flow: | 1225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.77 - 10.35) | Sell |
| Bollinger Bands (100): | (9.29 - 10.19) | Buy |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 42.52 | Sell |
| Chaikin Money Flow: | -234523 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.04 - 75.68) | Sell |
| Bollinger Bands (100): | (68.39 - 76.99) | Buy |
MTSFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.81 | Buy |
| 20-day SMA: | 9.98 | Sell |
| 50-day SMA: | 10 | Sell |
| 200-day SMA: | 9.5 | Buy |
| 8-day EMA: | 9.84 | Sell |
| 20-day EMA: | 9.93 | Sell |
| 50-day EMA: | 9.93 | Sell |
| 200-day EMA: | 9.36 | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.4 | Sell |
| 20-day SMA: | 74.45 | Sell |
| 50-day SMA: | 75.51 | Sell |
| 200-day SMA: | 70.84 | Buy |
| 8-day EMA: | 74.91 | Sell |
| 20-day EMA: | 74.89 | Sell |
| 50-day EMA: | 74.57 | Sell |
| 200-day EMA: | 70.13 | Buy |
Mitsui Fudosan Earnings Growth & MTSFF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
Mitsui Fudosan Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||